journal
Journals Expert Review of Molecular Dia...

Expert Review of Molecular Diagnostics

https://read.qxmd.com/read/39258858/how-can-we-improve-the-successful-identification-of-patients-suitable-for-car-t-cell-therapy
#1
REVIEW
Youqin Feng, Longyuan Wu, Tianning Gu, Yongxian Hu, He Huang
INTRODUCTION: In recent years, chimeric antigen receptor T (CAR-T) cell therapy has resulted in a breakthrough in the treatment of patients with refractory or relapsed hematological malignancies. However, the identification of patients suitable for CAR-T cell therapy needs to be improved. AREAS COVERED: CAR-T cell therapy has demonstrated excellent efficacy in hematological malignancies; however, views on determining when to apply CAR-T cells in terms of the evaluation of patient characteristics remain controversial...
September 11, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/39194060/implementing-next-generation-sequencing-for-diagnosis-and-management-of-hereditary-hearing-impairment-a-comprehensive-review
#2
JOURNAL ARTICLE
Cheng-Yu Tsai, Jacob Shu-Jui Hsu, Pei-Lung Chen, Chen-Chi Wu
INTRODUCTION: Sensorineural hearing impairment (SNHI), a common childhood disorder with heterogeneous genetic causes, can lead to delayed language development and psychosocial problems. Next-generation sequencing (NGS) offers high-throughput screening and high-sensitivity detection of genetic etiologies of SNHI, enabling clinicians to make informed medical decisions, provide tailored treatments, and improve prognostic outcomes. AREAS COVERED: This review covers the diverse etiologies of HHI and the utility of different NGS modalities (targeted sequencing and whole exome/genome sequencing), and includes HHI-related studies on newborn screening, genetic counseling, prognostic prediction, and personalized treatment...
August 28, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/39194003/recent-developments-in-molecular-targeted-therapies-for-hepatocellular-carcinoma-in-the-genomic-era
#3
REVIEW
Ugo Testa
INTRODUCTION: Primary liver cancer is a major health problem being the sixth most frequent cancer in the world and the third cause of cancer-related death in the world. The most common histological type of liver cancer is hepatocellular carcinoma (HCC, 75-80%). AREAS COVERED: Based on primary literature, this review provides an updated analysis of studies of genetic characterization of HCC at the level of gene mutation profiling, copy number alterations, and gene expression, with the definition of molecular subgroups and the identification of some molecular biomarkers and therapeutic targets...
August 28, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/39187988/a-systematic-review-and-meta-analysis-combined-with-bioinformatic-analysis-on-the-predictive-value-of-e-cadherin-in-patients-with-renal-cell-carcinoma
#4
REVIEW
Zikuan Zhang, Bo Xue, Yongquan Chen, Yuan Shao, Dongwen Wang
OBJECTIVES: Renal cell carcinoma (RCC) is the most common cancer of the kidney. This study aims to evaluate the potential predictive value of E-cadherin, a marker of the epithelial mesenchymal transit (EMT) process that has been associated with tumor metastasis. METHODS: We searched PubMed, Embase, and Cochrane Library to identify prospective studies. Hazard ratios (HRs), odds ratios (ORs), and 95% confidence intervals (CIs) were summarized to validate the relationship between E-cadherin and survival and clinical characteristics...
August 26, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/39158206/serum-biomarkers-for-predicting-microvascular-complications-of-diabetes-mellitus
#5
REVIEW
Jiajia Wang, Xiaoyi Song, Ziqiao Xia, Shu Feng, Hangfeng Zhang, Chengjie Xu, Hui Zhang
INTRODUCTION: Diabetic microvascular complications such as retinopathy, nephropathy, and neuropathy are primary causes of blindness, terminal renal failure, and neuropathic disorders in type 2 diabetes mellitus patients. Identifying reliable biomarkers promptly is pivotal for early detection and intervention in these severe complications. AREAS COVERED: This review offers a thorough examination of the latest research concerning serum biomarkers for the prediction and assessment of diabetic microvascular complications...
August 19, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/39135402/towards-improved-point-of-care-poc-testing-for-patients-with-suspected-sepsis-poc-tests-for-host-biomarkers-and-possible-microbial-pathogens
#6
REVIEW
Maria-Evangelia Adami, Evangelos J Giamarellos-Bourboulis, Effie Polyzogopoulou
INTRODUCTION: Sepsis is a heterogeneous syndrome often misdiagnosed. Point-of-care (POC) diagnostic tests are commonly used to guide decision and include host biomarkers and molecular diagnostics. AREAS COVERED: The diagnostic and prognostic accuracy of established and emerging biomarkers for sepsis, including procalcitonin (PCT) soluble urokinase plasminogen activator receptor (suPAR), presepsin, TRAIL/IP-10/CRP, MxA, and MxA-CRP, are analyzed in this review. The clinical utility of the two prevalent molecular techniques for pathogens identification using polymerase chain reaction (PCR) assays is also presented: FILMARRAY and QIAstat-Dx RP...
August 13, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/39132997/recent-advances-in-crispr-cas-systems-for-colorectal-cancer-research-and-therapeutics
#7
REVIEW
Saeideh Khorshid Sokhangouy, Farzaneh Alizadeh, Malihe Lotfi, Samaneh Sharif, Atefeh Ashouri, Yasamin Yoosefi, Saeed Bozorg Qomi, Mohammad Reza Abbaszadegan
INTRODUCTION: Colon cancer, ranked as the fourth leading global cause of cancer death, exhibits a complex progression marked by genetic variations. Over the past decade, the utilization of diverse CRISPR systems has propelled accelerated research into colorectal cancer (CRC) treatment. AREAS COVERED: CRISPR/Cas9, a key player in this research, identifies new oncogenes, tumor suppressor genes (TSGs), and drug-resistance genes. Additionally, it facilitates the construction of experimental models, conducts genome-wide library screening, and develops new therapeutic targets, especially for targeted knockout in vivo or molecular targeted drug delivery, contributing to personalized treatments and significantly enhancing the care of colon cancer patients...
August 12, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/39129222/biomarkers-of-sleep-wake-disturbance-as-predictors-of-cognitive-decline-and-accelerated-disease-progression
#8
JOURNAL ARTICLE
Aren Tucker, Terry E Goldberg, Hyun Kim
INTRODUCTION: In older adults, where sleep disturbances and cognitive impairment are common, mounting evidence suggests a potential connection between sleep and cognitive function, highlighting the significance of utilizing sleep as a biomarker for early detection of cognitive impairment to improve clinical outcomes in a noninvasive, cost-effective manner. AREAS COVERED: This review describes the relationship between sleep and cognitive function in older adults, encompassing both subjective and objective measures of sleep quality, duration, architecture, and sleep-disordered breathing...
August 11, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/39107971/the-current-clinical-applications-of-preimplantation-genetic-testing-pgt-acknowledging-the-limitations-of-biology-and-technology
#9
JOURNAL ARTICLE
Georgia Kakourou, Christalena Sofocleous, Thalia Mamas, Christina Vrettou, Joanne Traeger-Synodinos
INTRODUCTION: Preimplantation Genetic Testing (PGT) is a cutting-edge test used to detect genetic abnormalities in embryos fertilized through Medically Assisted Reproduction (MAR). PGT aims to ensure that embryos selected for transfer are free of specific genetic conditions or chromosome abnormalities, thereby reducing chances for unsuccessful MAR cycles, complicated pregnancies, and genetic diseases in future children. AREAS COVERED: In PGT, genetics, embryology and technology progress and evolve together...
August 6, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/39087770/an-overview-of-early-genetic-predictors-of-iga-deficiency
#10
REVIEW
Saba Fekrvand, Hassan Abolhassani, Nima Rezaei
INTRODUCTION: Inborn errors of immunity (IEIs) refer to a heterogeneous category of diseases with defects in the number and/or function of components of the immune system. Immunoglobulin A (IgA) deficiency is the most prevalent IEI characterized by low serum level of IgA and normal serum levels of IgG and/or IgM. Most of the individuals with IgA deficiency are asymptomatic and are only identified through routine laboratory tests. Others may experience a wide range of clinical features including mucosal infections, allergies, and malignancies as the most important features...
August 1, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/39086208/-cyp19a1-polymorphisms-and-bladder-cancer-risk-in-the-chinese-han-population
#11
JOURNAL ARTICLE
Jing Liang, Yongfei Li, Panpan Wan, Wenjing Zhang, Junhui Han, Man Zhang, Bin Li, Tianbo Jin
BACKGROUND: The expression of CYP19A1 has implications for the prognosis of female bladder cancer. However, this study aimed to explore the association between single nucleotide polymorphisms (SNPs) in CYP19A1 and bladder cancer risk, as no prior research has addressed this association. RESEARCH DESIGN AND METHODS: We selected and genotyped five CYP19A1 SNPs (rs4646, rs6493487, rs1062033, rs17601876, and rs3751599) in 217 patients and 550 controls using the Agena MassARRAY system...
July 31, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/39054637/interpreting-the-results-of-rapid-molecular-diagnostic-tests-for-carbapenem-resistant-enterobacterales-infection-current-clinical-perspective-while-waiting-for-further-evidence
#12
JOURNAL ARTICLE
Daniele Roberto Giacobbe, Vincenzo Di Pilato, Antonio Vena, Anna Marchese, Matteo Bassetti
INTRODUCTION: Carbapenem-resistant Enterobacterales (CRE) causing severe infections in humans have represented an important challenge for clinicians worldwide during the past two decades. AREAS COVERED: Novel β-lactams and β-lactam/β-lactamase inhibitor combinations have led to a shift in the first-line approach to the treatment of severe CRE infections from polymyxin-based regimens to treatment with less toxic agents. This new scenario offers the opportunity to apply rapid molecular diagnostic tests for CRE infection to identify different types of carbapenemases...
July 25, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/39054633/-68-ga-psma-11-for-positron-emission-tomography-pet-imaging-of-prostate-specific-membrane-antigen-psma-positive-lesions-in-men-with-prostate-cancer
#13
JOURNAL ARTICLE
Jessica Clore, Peter J H Scott
INTRODUCTION: Theranostics targeting prostate-specific membrane antigen (PSMA) represent a new targeted approach for prostate cancer care that combines diagnostic and therapeutic radiopharmaceuticals to diagnose and treat the disease. Positron emission tomography (PET) is the imaging method of choice and several diagnostic radiopharmaceuticals for quantifying PSMA have received FDA approval and are in clinical use. [68 Ga]Ga-PSMA-11 is one such imaging agent and the focus of this article...
July 25, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/39054632/the-impact-of-next-generation-sequencing-for-diagnosis-and-disease-understanding-of-myeloid-malignancies
#14
REVIEW
Erica Vormittag-Nocito, Madina Sukhanova, Lucy A Godley
INTRODUCTION: Defining the chromosomal and molecular changes associated with myeloid neoplasms (MNs) optimizes clinical care through improved diagnosis, prognosis, treatment planning, and patient monitoring. This review will concisely describe the techniques used to profile MNs clinically today, with descriptions of challenges and emerging approaches that may soon become standard-of-care. AREAS COVERED: In this review, the authors discuss molecular assessment of MNs using non-sequencing techniques, including conventional cytogenetic analysis, fluorescence in situ hybridization, chromosomal genomic microarray testing; as well as DNA- or RNA-based next-generation sequencing (NGS) assays; and sequential monitoring via digital PCR or measurable residual disease assays...
July 25, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/38995110/the-role-of-fecal-biomarkers-in-individuals-with-inflammatory-bowel-disease
#15
REVIEW
Teagan S Edwards, Andrew S Day
INTRODUCTION: Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and Ulcerative Colitis (UC), is a relapsing and remitting condition. Noninvasive biomarkers have an increasingly important role in the diagnosis of IBD and in the prediction of future disease course in individuals with IBD. Strategies for the management of IBD increasingly rely upon close monitoring of gastrointestinal inflammation. AREAS COVERED: This review provides an update on the current understanding of established and novel stool-based biomarkers in the diagnosis and management of IBD...
July 12, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/38973430/point-of-care-isothermal-nucleic-acid-amplification-tests-progress-and-bottlenecks-for-extraction-free-sample-collection-and-preparation
#16
REVIEW
Alexis F Wilkinson, Maria J Barra, Emilie N Novak, Meaghan Bond, Rebecca Richards-Kortum
INTRODUCTION: Suitable sample collection and preparation methods are essential to enable nucleic acid amplification testing at the point of care (POC). Strategies that allow direct isothermal nucleic acid amplification testing (iNAAT) of crude sample lysate without the need for nucleic acid extraction minimize time to result as well as the need for operator expertise and costly infrastructure. AREAS COVERED: The authors review research to understand how sample matrix and preparation affect the design and performance of POC iNAATs...
July 8, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/38973412/are-we-closer-to-robust-predictors-of-recurrent-pregnancy-loss-by-means-of-integrating-different-types-of-omics-data
#17
EDITORIAL
Yiqiu Wei, Zhimin Deng, Tailang Yin
No abstract text is available yet for this article.
July 8, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/38958430/correlation-between-lipoprotein-associated-phospholipase-a2-and-poststroke-mild-cognitive-impairment
#18
JOURNAL ARTICLE
Yawei Cao, Xiaofeng Zhu, Jin Shang, Jinlong Zheng, Xiangyang Tian, Qiu Han, Jun Shen
OBJECTIVES: This study aimed to investigate the correlation between serum lipoprotein-associated phospholipase A2 (Lp-PLA2) and poststroke mild cognitive impairment (PSMCI). METHODS: The patients included in the study were divided into PSMCI (68 cases) and cognitively normal (CN) (218 cases) groups and followed up for six months. Demographic and clinical data were collected. A logistic regression analysis was performed to determine whether Lp-PLA2 is an independent risk factor for PSMCI...
July 3, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/38924448/current-status-of-diagnostic-assays-for-emerging-zoonotic-viruses-nipah-and-hendra
#19
REVIEW
Nancy Sharma, Vijay Lakshmi Jamwal, Sakshi Nagial, Manish Ranjan, Dharitri Rath, Sumit G Gandhi
INTRODUCTION: Nipah and Hendra viruses belong to the Paramyxoviridae family, which pose a significant threat to human health, with sporadic outbreaks causing severe morbidity and mortality. Early symptoms include fever, cough, sore throat, and headache, which offer little in terms of differential diagnosis. There are no specific therapeutics and vaccines for these viruses. AREAS COVERED: This review comprehensively covers a spectrum of diagnostic techniques for Nipah and Hendra virus infections, discussed in conjunction with appropriate type of samples during the progression of infection...
June 26, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/38904089/metabolomics-for-searching-validated-biomarkers-in-cancer-studies-a-decade-in-review
#20
REVIEW
Ángeles López-López, Ángeles López-Gonzálvez, Coral Barbas
INTRODUCTION: In the dynamic landscape of modern healthcare, the ability to anticipate and diagnose diseases, particularly in cases where early treatment significantly impacts outcomes, is paramount. Cancer, a complex and heterogeneous disease, underscores the critical importance of early diagnosis for patient survival. The integration of metabolomics information has emerged as a crucial tool, complementing the genotype-phenotype landscape and providing insights into active metabolic mechanisms and disease-induced dysregulated pathways...
June 21, 2024: Expert Review of Molecular Diagnostics
journal
journal
39742
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.